BioSante Pharma (BPAX) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts BPAX Hot Sheet
Price: $1.09 --0%
Financial Fact:
BASIC NET LOSS PER SHARE (in dollars per share): 0.22
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
BASIC NET LOSS PER SHARE (in dollars per share): 0.22
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) reported Q1 loss of $0.20, $0.06 worse than the analyst estimate of ($0.14).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- AAR Corp. (AIR) Tops Q1 EPS by 18c
- Acuity Brands (AYI) Tops Q4 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
